Lemon grass (Cymbopogon citratus) ameliorates murine spontaneous ileitis by decreasing lymphocyte recruitment to the inflamed intestine

Microcirculation

Volumn 17, Issue 5, 2010, Pages 321-332

  Watanabe, Chikako ^a   Hokari, Ryota ^a   Komoto, Shunsuke ^a   Kurihara, Chie ^a   Okada, Yoshikiyo ^a   Matsunaga, Hisayuki ^a   Takebayashi, Koichi ^a   Kawaguchi, Atsushi ^a   Nagao, Shigeaki ^a   Tsuzuki, Yoshikazu ^a   Yokoyama, Hirokazu ^b   Hibi, Toshifumi ^b   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

7 integrin; CCR9; intestinal microvessels; lymphocytes; retinoic acid

Indexed keywords

BETA7 INTEGRIN; CHEMOKINE RECEPTOR CCR9; RETINOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; CYMBOPOGON CITRATUS; DIET THERAPY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG SYNTHESIS; ENTERITIS; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; ILEITIS; ILEUM MUCOSA; LEUKOCYTE MIGRATION; LONG TERM CARE; LYMPHOCYTE; LYMPHOCYTE MIGRATION; MICROSCOPY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ALCOHOL OXIDOREDUCTASES; ANIMALS; CELL MOVEMENT; CYMBOPOGON; ILEITIS; ILEUM; INTEGRIN BETA CHAINS; INTESTINAL MUCOSA; MICE; MICE, INBRED AKR; MICROSCOPY, FLUORESCENCE; MICROVESSELS; PHYTOTHERAPY; RECEPTORS, CCR; RNA, MESSENGER; T-LYMPHOCYTES; TRETINOIN;

CYMBOPOGON CITRATUS; MURINAE; MUS;

EID: 77954324845     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2010.00032.x     Document Type: Article

References (31)

1. Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F, Ley KF, Lindner JR, Pizarro TT. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology 130 : 8 16, 2006.
2. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, McEvoy LM, Butcher EC, Kassam N, Mackay CR, Newman W, Ringler DJ. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 151 : 97 110, 1997.
3. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol 72 : 209 253, 1999.
4. Connor MJ, Smit MH. Terminal-group oxidation of retinol by mouse epidermis. Inhibition in vitro and in vivo. Biochem J 244 : 489 492, 1987.
5. Fujimori H, Miura S, Koseki S, Hokari R, Komoto S, Hara Y, Hachimura S, Kaminogawa S, Ishii H. Intravital observation of adhesion of lamina propria lymphocytes to microvessels of small intestine in mice. Gastroenterology 122 : 734 744, 2002.
6. Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnálek P, Zádorová Z, Palmer T, Donoghue S Natalizumab Pan-European Study Group. Natalizumab for active Crohn's disease. N Engl J Med 348 : 24 32, 2003.
7. Hosoe N, Miura S, Watanabe C, Tsuzuki Y, Hokari R, Oyama T, Fujiyama Y, Nagata H, Ishii H. Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa. Am J Physiol Gastrointest Liver Physiol 286 : G458 G466, 2004.
8. Inoue T, Tsuzuki Y, Matsuzaki K, Matsunaga H, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K, Matsumoto S, Miura S. Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice. J Leukoc Biol 77 : 287 295, 2005.
9. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 : 527 538, 2004.
10. Iwata M, Mukai M, Nakai Y, Iseki R. Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J Immunol 149 : 3302 3308, 1992.
11. Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Márquez G, Agace W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 198 : 963 969, 2003.
12. Matsumoto S, Okabe Y, Setoyama H, Takayama K, Ohtsuka J, Funahashi H, Imaoka A, Okada Y, Umesaki Y. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43 : 71 78, 1998.
13. Matsuzaki K, Tsuzuki Y, Matsunaga H, Inoue T, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K, Matsumoto S, Miura S. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin Exp Immunol 140 : 22 31, 2005.
14. Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, Von Andrian UH. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424 : 88 93, 2003.
15. Natl Toxicol Program Tech Rep Ser. Toxicology and Carcinogenesis Studies of Citral (Microencapsulated) (CAS No. 5392-40-5) in F344/N rats and B6C3F1 mice (feed studies) U.S. Department of Health and Human Services 2003. http://ntp.niehs.nih.gov/ntp/htdocs/LT-rpts/tr505.pdf
16. Okada Y, Tsuzuki Y, Miyazaki J, Matsuzaki K, Hokari R, Komoto S, Kato S, Kawaguchi A, Nagao S, Itoh K, Watanabe T, Miura S. Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut 55 : 681 688, 2006.
17. Onawunmi GO, Yisak WA, Ogunlana EO. Antibacterial constituents in the essential oil of Cymbopogon citratus (DC.) Stapf. J Ethnopharmacol 12 : 279 286, 1984.
18. Panes J, Granger DN. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114 : 1066 1090, 1998.
19. Papadakis KA, Landers C, Prehn J, Kouroumalis EA, Moreno ST, Gutierrez-Ramos JC, Hodge MR, Targan SR. CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profile. J Immunol 171 : 159 165, 2003.
20. Papadakis KA, Prehn J, Moreno ST, Cheng L, Kouroumalis EA, Deem R, Breaverman T, Ponath PD, Andrew DP, Green PH, Hodge MR, Binder SW, Targan SR. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology 121 : 246 254, 2001.
21. Picarella D, Hurlbut P, Rottman J, Shi X, Butcher E, Ringler DJ. Monoclonal antibodies specific for β7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells. J Immunol 158 : 2099 2106, 1997.
22. Reif S, Klein I, Lubin F, Shi X, Butcher E, Ringler DJ. Pre-illness dietary factors in inflammatory bowel disease. Gut 40 : 754 760, 1997.
23. Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, Panaccione R, Sanders M, Schreiber S, Targan S, van Deventer S, Goldblum R, Despain D, Hogge GS, Rutgeerts P. Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med 353 : 1912 1925, 2005.
24. Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology 122 : 1592 1608, 2002.
25. Saruta M, Yu QT, Avanesyan A, Fleshner PR, Targan SR, Papadakis KA Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease. J Immunol 178 : 3293 3300, 2007.
26. Sommer A, Tarwotjo I, Djunaedi E, West KP Jr., Loeden AA, Tilden R, Mele L. Impact of vitamin A supplementation on childhood mortality. A randomised controlled community trial. Lancet 1 : 1169 1173, 1986.
27. Sommer A. Vitamin A deficiency, child health, and survival. Nutrition 13 : 484 485, 1997.
28. Takebayashi K, Hokari R, Kurihara C, Okada Y, Okudaira K, Matsunaga H, Komoto S, Watanabe C, Kawaguchi A, Nagao S, Tsuzuki Y, Miura S. Oral tolerance induced by enterobacteria altered the process of lymphocyte recruitment to intestinal microvessels: roles of endothelial cell adhesion molecules, TGF-beta and negative regulators of TLR signaling. Microcirculation 16 : 251 264, 2009.
29. Targan SR, Feagan BG, Fedorak RN, Lashner BA, Panaccione R, Present DH. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology 132 : 1672 1683, 2007. (Pubitemid 46695722)
30. Yokoyama H, Matsumoto M, Shiraishi H, Ishii H. Simultaneous quantification of various retinoids by high performance liquid chromatography: its relevance to alcohol research. Alcohol Clin Exp Res 24 : 26S 29S, 2000.
31. Van Assche G., Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 353 : 362 368, 2005.